Bone tissue engineering: A review in bone biomimetics and drug delivery strategies
By Joshua R. Porter, Timothy T. Ruckh, K. Popat. Biotechnology progress (Print), 2009
756 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Rheumatology
View Paper: https://www.semanticscholar.org/paper/96ff0867a8e26fa2a409189700af2c92932e9a60
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
In Rheumatology
Citations in the corpus
- Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review (2011, background): “, growth factors, such as bone morphogenetic proteins (BMPs) and vascular endothelial growth factors (VEGFs)) [7,12,13].”
- Bone substitutes in orthopaedic surgery: from basic science to clinical practice (2014, background): “Although local delivery of antibiotics has a very promising outlook, there remains a number of challenges (such as antibiotic stability within the scaffold and antibiotic deactivation during fabrication), which need to be addressed before clinical trials can begin [170].”
- Natural Polymeric Scaffolds in Bone Regeneration (2020, background): “These principles consist in numerous strategies including gene therapy, drug and growth factor delivery, stem cell transplantation, and engineering of acellular scaffolds (Porter et al., 2009).”
- Inflammation, Fracture and Bone Repair (2016, background): “Upon bone injury, macrophages release various cytokines, chemokines, and growth factors to recruit additional inflammatory cells, promote neovascularization, direct MSC migration and differentiation, and mediate remodeling [6,87,88].”
- Collagen for bone tissue regeneration. (2012, background): “ment to exploit the natural biological response to tissue damage, and incorporating engineering and life science principles [45,46].”